In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 3: Interpretation and reports

This document gives the general requirements for interpretation and reporting of multiplex molecular tests which simultaneously identify two or more nucleic acid target sequences of interest. This document is applicable to all multiplex methods used for examination using in vitro diagnostic (IVD) medical devices and laboratory developed tests (LDTs). It provides information for both qualitative and quantitative detection of nucleic acid target sequences.

This document is intended as guidance for multiplex examinations that detect or quantify human nucleic acid target sequences and microbial pathogen nucleic acid target sequences from human clinical specimens.

This document is applicable to any molecular IVD examination performed by medical laboratories. It is also intended to be used by laboratory customers, IVD developers and manufacturers, biobanks, institutions, commercial organizations performing biomedical research, and regulatory authorities. This document is not applicable to metagenomic massive parallel sequencing (MPS), but it is applicable to multiplex molecular methods including 16S sequencing.

Edition	2024
Standard Part No	3
Published Date	2024
Published By	International Standardization Organisation
Page Count	14

ISO

ISO 21474-3:2024

ISO 21483:2013

ISO 21485:2013

ISO 21527 2:2008

ISO 21528 2:2017

ISO 21527 1:2008

ISO 21543:2006

ISO 21567:2004

ISO 21572:2019

ISO 21573-1:2006

ISO 21593:2019

ISO 21600:2019